Shandong Sanyuan Biotechnology Co Ltd is a China-based company mainly engaged in the production and sales of new sweetener products. The Company's main products are erythritol and compound sugar. The compound sugar products include momordica grosvenori compound sugar, stevia compound sugar, sucralose compound sugar and others. The Company's products are sold to America, Europe, Africa, Oceania and other regions.

Employees

436

Sector

Food Processing

Calendar

31/07 - Extraordinary Shareholders Meeting

More about the company

Quotes

Date	Price	Change	Volume
18/25/18	29.91 ¥	-0.50%	18,57,600
17/25/17	30.06 ¥	+1.28%	21,43,300
16/25/16	29.68 ¥	+0.95%	20,91,055
15/25/15	29.40 ¥	-2.62%	29,83,950
14/25/14	30.19 ¥	+0.70%	20,20,537

End-of-day quote Shenzhen S.E., July 18, 2025

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

1

Last Close Price

29.91CNY

Average target price

32.00CNY

Spread / Average Target

+6.99%

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

End-of-day quote Shenzhen S.E. Other stock markets 18/07/2025			5-day change	1st Jan Change
29.91 ^CNY	-0.50%		-1.32%	+14.12%

16/07	US Imposes Nearly 451% Anti-Dumping Duties on Sanyuan Biotechnology's Sweeteners	MT
10/07	Shandong Sanyuan Biotechnology's shareholder to cut stakes	RE

Capitalization	599.55Cr 84Cr 72Cr 67Cr 62Cr 114.6Cr 7.19TCr 127.96Cr 806.51Cr 304.45Cr 3.37TCr 313.24Cr 306.75Cr 12TCr	P/E ratio 2025 *	37.4x	P/E ratio 2026 *	-
Enterprise value	599.55Cr 84Cr 72Cr 67Cr 62Cr 114.6Cr 7.19TCr 127.96Cr 806.51Cr 304.45Cr 3.37TCr 313.24Cr 306.75Cr 12TCr	EV / Sales 2025 *	6.81x	EV / Sales 2026 *	-
Free-Float	30.75%	Yield 2025 *	1.34%	Yield 2026 *	-

US Imposes Nearly 451% Anti-Dumping Duties on Sanyuan Biotechnology's Sweeteners	16/07	MT
Shandong Sanyuan Biotechnology's shareholder to cut stakes	10/07	RE
Tranche Update on Shandong Sanyuan Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on July 9, 2024.	09/07	CI
Shandong Sanyuan Biotechnology Co.,Ltd.'s Equity Buyback announced on July 9, 2024, has closed with 2,325,700 shares, representing 1.15% for CNY 60.68 million.	08/07	CI
Tranche Update on Shandong Sanyuan Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on July 9, 2024.	01/07	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	28/04	CI
Tranche Update on Shandong Sanyuan Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on July 9, 2024.	01/04	CI
Certain A Shares of Shandong Sanyuan Biotechnology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2025.	10/02	CI
EU imposes anti-dumping tariffs on Chinese sweetener erythritol	16/01	RE
Tranche Update on Shandong Sanyuan Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on July 9, 2024.	02/01	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	29/24/29	CI
Tranche Update on Shandong Sanyuan Biotechnology Co.,Ltd.'s Equity Buyback Plan announced on July 9, 2024.	08/24/08	CI
Shandong Sanyuan Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	29/24/29	CI

1 day	-0.50%
1 week	-1.32%
Current month	+3.82%
1 month	+4.29%
3 months	+4.87%
6 months	+16.93%
Current year	+14.12%

Shandong Sanyuan Biotechnology Co.,Ltd. Share Price

Equities

301206

CNE100005774

Food Processing

Valuation: Shandong Sanyuan Biotechnology Co.,Ltd.

Chart: Shandong Sanyuan Biotechnology Co.,Ltd.

Latest news: Shandong Sanyuan Biotechnology Co.,Ltd.

News in other languages: Shandong Sanyuan Biotechnology Co.,Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: Shandong Sanyuan Biotechnology Co.,Ltd.

Sugar & Artificial Sweeteners

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Annual profits - Rate of surprise

1 week	29.11	30.27
1 month	27.27	34.69
Current year	22.95	34.69
1 year	22.95	34.69
3 years	20.8	46.8
5 years	20.8	97.33
10 years	20.8	97.33

Manager	Title	Age	Since
Bao Hua Cheng CEO	Chief Executive Officer	60	14/11/2012
Jun Ling Yu DFI	Director of Finance/CFO	54	24/12/2019
Hong Fu Wei PRN	Corporate Officer/Principal	38	01/09/2009

Director	Title	Age	Since
Zai Jian Nie CHM	Chairman	74	01/11/2012
De Chun Li BRD	Director/Board Member	73	14/11/2012
Hong Fu Wei BRD	Director/Board Member	38	14/11/2012

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
SHANDONG SANYUAN BIOTECHNOLOGY CO.,LTD.	-0.50%	-1.32%	+24.78%	-28.10%	84Cr
COSUMAR SA	+1.92%	+1.88%	+35.77%	+18.18%	270.67Cr
SÜDZUCKER AG	+0.40%	-3.84%	-23.53%	-25.58%	235.85Cr
BALRAMPUR CHINI MILLS LIMITED	+0.41%	+0.86%	+37.22%	+67.78%	144.37Cr
GUANGXI YUEGUI GUANGYE HOLDINGS CO., LTD.	+1.90%	+3.17%	+154.64%	+91.47%	135.41Cr
SHANDONG BAILONG CHUANGYUAN BIO-TECH CO., LTD.	+0.13%	+4.88%	+53.73%	+115.75%	130.58Cr
SÃO MARTINHO S.A.	+4.32%	+4.32%	-44.50%	-47.60%	104.24Cr
ADECOAGRO S.A.	-0.42%	+0.58%	+0.37%	+28.45%	95Cr
TRIVENI ENGINEERING & INDUSTRIES LIMITED	+0.32%	-1.75%	-13.70%	+46.54%	92Cr
HONGMIAN ZHIHUI SCIENCE AND TECHNOLOGY INNOVATION CO.,LTD.GUANGZHOU	0.00%	-2.41%	+21.35%	-7.43%	82Cr
Average	+0.92%	-0.27%	+24.61%	+25.95%	137.45Cr
Weighted average by Cap.	+1.09%	-0.82%	+25.77%	+25.64%

	2025 *	2026 *
Net sales	88Cr 12Cr 11Cr 9.81Cr 9.13Cr 17Cr 1.06TCr 19Cr 118.51Cr 45Cr 495.5Cr 46Cr 45Cr 1.82TCr	-
Net income	16Cr 2.26Cr 1.94Cr 1.8Cr 1.68Cr 3.1Cr 194.33Cr 3.46Cr 22Cr 8.23Cr 91Cr 8.46Cr 8.29Cr 334.92Cr	-
Net Debt	-	-